• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

碳酸氢钠可缓解阴茎海绵体内注射治疗勃起功能障碍所致的阴茎疼痛。

Sodium bicarbonate alleviates penile pain induced by intracavernous injections for erectile dysfunction.

作者信息

Moriel E Z, Rajfer J

机构信息

Department of Surgery, UCLA School of Medicine.

出版信息

J Urol. 1993 May;149(5 Pt 2):1299-300. doi: 10.1016/s0022-5347(17)36373-5.

DOI:10.1016/s0022-5347(17)36373-5
PMID:8386779
Abstract

In an attempt to determine whether penile pain associated with intracorporeal injections could be due to the acidity of the medication, we performed a randomized study comparing the incidence of penile pain following intracorporeal injections with or without the addition of sodium bicarbonate to the intracorporeal medications. A total of 38 consecutive patients who presented to our clinic with impotence received 0.2 ml. of a combination of 3 drugs: 6 mg. papaverine, 100 micrograms. phentolamine and 10 micrograms. prostaglandin E1 with (pH 7.05) or without (pH 4.17) the addition of sodium bicarbonate (0.03 mEq.). Of the 19 patients without sodium bicarbonate added to the medication 11 (58%) complained of penile pain due to the medication, while only 1 of the 19 men (5%) who received sodium bicarbonate complained of penile pain. From these data we conclude that the penile pain following intracorporeal injections is most likely due to the acidity of the medication, which can be overcome by elevating the pH to a neutral level.

摘要

为了确定阴茎海绵体内注射相关的阴茎疼痛是否可能归因于药物的酸度,我们进行了一项随机研究,比较了在阴茎海绵体内药物中添加或不添加碳酸氢钠情况下阴茎海绵体内注射后阴茎疼痛的发生率。共有38例因阳痿前来我们诊所就诊的连续患者接受了0.2毫升由三种药物组成的合剂:6毫克罂粟碱、100微克酚妥拉明和10微克前列腺素E1,其中一组添加了碳酸氢钠(0.03毫当量,pH值7.05),另一组未添加(pH值4.17)。在未添加碳酸氢钠的19例患者中,11例(58%)因药物注射而抱怨阴茎疼痛,而在接受了碳酸氢钠的19例男性中,只有1例(5%)抱怨阴茎疼痛。根据这些数据我们得出结论,阴茎海绵体内注射后的阴茎疼痛很可能归因于药物的酸度,通过将pH值提高到中性水平可以克服这一问题。

相似文献

1
Sodium bicarbonate alleviates penile pain induced by intracavernous injections for erectile dysfunction.碳酸氢钠可缓解阴茎海绵体内注射治疗勃起功能障碍所致的阴茎疼痛。
J Urol. 1993 May;149(5 Pt 2):1299-300. doi: 10.1016/s0022-5347(17)36373-5.
2
Objective double-blind evaluation of erectile function with intracorporeal papaverine in combination with phentolamine and/or prostaglandin E1.采用双盲法评估阴茎海绵体内注射罂粟碱联合酚妥拉明和/或前列腺素E1对勃起功能的影响。
J Urol. 1992 Oct;148(4):1181-3. doi: 10.1016/s0022-5347(17)36853-2.
3
Double-blind, cross-over study comparing prostaglandin E1 and papaverine in patients with vasculogenic impotence.比较前列腺素E1和罂粟碱治疗血管性阳痿患者的双盲交叉研究。
Urology. 1991 Jun;37(6):516-8. doi: 10.1016/0090-4295(91)80314-w.
4
Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison.前列腺素E1与酚妥拉明/罂粟碱治疗勃起功能障碍的双盲比较
J Urol. 1989 Mar;141(3):549-50. doi: 10.1016/s0022-5347(17)40889-5.
5
Alkalization does not alleviate penile pain induced by intracavernous injection of prostaglandin E1.碱化并不能缓解海绵体内注射前列腺素E1所引起的阴茎疼痛。
J Urol. 1996 Sep;156(3):999-1000.
6
Intracavernous injection of prostaglandin E1 plus procaine in the treatment of erectile dysfunction.海绵体内注射前列腺素E1加普鲁卡因治疗勃起功能障碍。
J Urol. 1994 Oct;152(4):1108-10. doi: 10.1016/s0022-5347(17)32515-6.
7
[Current role of intracavernous therapy in the treatment of erectile dysfunction].[海绵体内注射疗法在勃起功能障碍治疗中的当前作用]
Arch Esp Urol. 2002 Jun;55(5):475-82.
8
[Intracavernous injection of vasoactive drugs for treating erectile impotence].[海绵体内注射血管活性药物治疗勃起功能障碍]
Hinyokika Kiyo. 1988 Feb;34(2):301-4.
9
Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.前列腺素E1联合酚妥拉明治疗勃起功能障碍
Int J Impot Res. 1996 Mar;8(1):5-7.
10
Comparison of a mixture of papaverine, phentolamine and prostaglandin E1 with other intracavernous injections.罂粟碱、酚妥拉明和前列腺素E1混合物与其他海绵体内注射剂的比较。
Eur Urol. 1994;26(4):319-21. doi: 10.1159/000475407.

引用本文的文献

1
A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient?勃起功能障碍治疗方案的比较性综述:何种治疗适用于何种患者?
Drugs. 2005;65(12):1621-50. doi: 10.2165/00003495-200565120-00003.
2
Intracavernous pharmacotherapy for erectile dysfunction.阴茎海绵体内药物治疗勃起功能障碍。
Endocrine. 2004 Mar-Apr;23(2-3):149-55. doi: 10.1385/ENDO:23:2-3:149.
3
Comparative tolerability and efficacy of treatments for impotence.阳痿治疗方法的耐受性和疗效比较
Drug Saf. 1999 Feb;20(2):133-46. doi: 10.2165/00002018-199920020-00004.
4
Intracavernous alprostadil. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in erectile dysfunction.海绵体内注射前列地尔。其药效学、药代动力学特性及在勃起功能障碍中的治疗潜力综述。
Drugs Aging. 1996 Jan;8(1):56-74. doi: 10.2165/00002512-199608010-00009.
5
Pharmacological management of erectile dysfunction.勃起功能障碍的药物治疗
Drugs. 1995 Sep;50(3):465-79. doi: 10.2165/00003495-199550030-00005.